Teratogenic effects of antiepileptic drugs

Seizure

Volumn 17, Issue 2, 2008, Pages 166-171

  Tomson, Torbjörn ^a   Battino, Dina ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Antiepileptic drugs; Epilepsy; Malformations; Teratogenic

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ARTICLE; BIRTH DEFECT; CLINICAL TRIAL; COGNITIVE DEVELOPMENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISEASE CONTROL; HUMAN; HYPOSPADIAS; MONOTHERAPY; NEURAL TUBE DEFECT; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SEIZURE; TERATOGENESIS; TREATMENT OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 38949085556     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.11.016     Document Type: Article

References (31)

1. Meadow S.R. Anticonvulsant drugs and congenital abnormalities. Lancet 2 7581 (1968) 1296
2. Tomson T., and Battino D. Teratogenicity of antiepileptic dtugs: state of the art. Curr Opin Neurol 18 (2005) 135-140
3. Samren E.B., van Duijn C.M., Christiaens G.C., Hofman A., and Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46 (1999) 739-746
4. Olafsson E., Hallgrimsson J.T., Hauser W.A., Ludvigsson P., and Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39 8 (1998) 887-892
5. Kaneko S., Battino D., Andermann E., Wada K., Kan R., Takeda A., et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 33 2/3 (1999) 145-158
6. Fried S., Kozer E., Nulman I., Einarson T.R., and Koren G. Malformation rates in children of women with untreated epilepsy. A meta-analysis. Drug Saf 27 (2004) 197-202
7. Samren E.B., van Duijn C.M., Koch S., Hiilesmaa V.K., Klepel H., Bardy A.H., et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38 (1997) 981-990
8. Kaaja E., Kaaja R., and Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 60 4 (2003) 575-579
9. Wide K., Winbladh B., and Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93 2 (2004) 174-176
10. Artama M., Auvinen A., Raudaskoski T., Isojarvi I., and Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64 11 (2005) 1874-1878
11. Morrow J.I., Russell A., Gutherie E., Parsons L., Robertson I., Waddell R., et al. Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77 (2006) 193-198
12. Lindhout D., Hoppener R.J., and Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 25 1 (1984) 77-83
13. Cunnington M., Tennis P., and The International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 64 (2005) 955-960
14. Vajda F.J.E., Hitchcock A., Graham J., et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 13 (2006) 645-654
15. Cunnington M., Ferber S., Quarteny G., and The International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Effect of dose on frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48 6 (2007) 1207-1210
16. Robert E., Lofkvist E., Mauguiere F., and Robert J.M. Evaluation of drug therapy and teratogenic risk in Rhone-Alpes district population of pregnant women. Eur Neurol 25 (1986) 436-443
17. Jager-Roman E., Deichl A., Jakob S., Hartmann A.M., Koch S., Rating D., et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 108 6 (1986) 997-1004
18. Kallen A.J. Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8 3 (1994) 203-205
19. Holmes L.B., Wyszynski D.F., Baldwin E.J., Habecker E., Glassman L.H., and Smith C.R. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy. Birth Defects Res (A) Clin Mol Teratol 76 (2006) 318
20. The EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology 66 (2006) 354-360
21. Holmes L.B., Harvey E.A., Coull B.A., Huntington K.B., Khoshbin S., Hayes A.M., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 344 (2001) 1132-1138
22. Holmes L.B., Wyszynski D.F., and Lieberman E.S. The AED (antiepileptic drug) Pregnancy Registry: a 6-year experience. Arch Neurol 61 (2004) 673-678
23. Wyszynski D.F., Nambisan M., Surve T., Alsdorf R.M., Smith C.R., and Holmes L.B. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 (2005) 961-965
24. Hernandez-Diaz S., Smith C.R., Wyszynski D.F., and Holmes L.B. Risk of major malformations among infants exposed to carbamazepine during pregnancy. Birth Defects Res A: Clin Mol Teratol 79 (2007) 357
25. Meischenguiser R., D'Giano C.H., and Ferraro Sm. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 5 (2004) 163-167
26. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4 3 (2003) 310-317
27. Hunt S., Craig J., Russell A., Guthrie E., Parsons L., Robertson I., et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 67 (2006) 1876-1879
28. Adab N., Tudur S.C., Vinten J., Williamson P., and Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy (Cochrane review) (2004), John Wiley & Sons Ltd, Cochrane Libruary, Chichester, UK Issue 3
29. Adab N., Kini U., Vinten J., Ayres J., Baker G., Clayton-Smith J., et al. The long term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004) 1575-1583
30. Gaily E., Kantola-Sorsa E., Hiilesmaa V., Isoaho M., Matila R., Kotila M., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62 1 (2004) 28-32
31. Eriksson K., Viinikainen K., Monkkonen A., Aikia M., Nieminen P., Heinonen S., et al. Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65 3 (2005) 189-200